ArticleDiabetology international2025
A case of slowly progressive type 1 diabetes accompanied by positivity for a single islet cell antibody, initially suspected to be childhood-onset type 2 diabetes or maturity-onset diabetes of the young.
Article in Diabetology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Revealing Monogenic Diabetes: Clinical and Genetic Features of Pediatric MODY Cases in Türkiye: Single Center Experience.Pediatric diabetes · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We encountered a 19-year-old woman who was found to have glucosuria (3+) on urinalysis at school at the age of 11 years and 10 months. She had a three-generation family history of diabetes. She was 150.6 cm tall (+ 0.28 standard deviations (SD)), weighed 50.8 kg (+ 1.0 SD), and did not have obesity or deafness. She had a glycated hemoglobin (HbA1c) of 10.9%, blood glucose of 334 mg/dL, negativity for urine ketones, serum C-peptide concentration of 1.63 ng/mL, and negativity for anti-glutamic acid decarboxylase (GAD) and tyrosine phosphatase-like protein IA-2 (IA-2) autoantibodies. The patient was initially diagnosed with childhood-onset type 2 diabetes mellitus without obesity because she could be weaned off insulin treatment within 1 month. Her HbA1c level was maintained at 6% using diet and metformin for 3 years after, but deteriorated to 9.9% in the 4th year. Subsequently, the oral hypoglycemic regimen was strengthened, but her HbA1c rose even higher. She stopped attending hospital for 19 months, but at the age of 19 years and 11 months, she was urgently admitted to our hospital with diabetic ketoacidosis, when her fasting serum C-peptide concentration had decreased to 0.49 ng/mL. No mutations in maturity-onset diabetes of the young-related genes were identified. She was negative for anti-GAD, IA-2, and zinc transporter 8 antibodies, but positive for islet cell antibody, confirming a diagnosis of slowly progressive type 1 diabetes. Therefore, the type of diabetes present in children and adolescents should be diagnosed with great care and reconsidered according to the clinical course.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.